Research update


Orexo: Zubsolv Rx Data week 49

According to latest Symphony Health Solutions Rx data, Zubsolv tablets showed a market share of 5.97% (6.03%), 4-week rolling average. The total number of Zubsolv tablets sold week 49 (48) reaching 337,072 (347,959). Zubsolv prescriptions (TRx) recorded a market share of 5.98% (6.07%), 4-week rolling average. Total number of prescriptions reaching 11,865 (12,413) during the week.

The overall market (buprenorphine/naloxone products) showed a y/y growth rate of 7.6% (7.3%) (4-week rolling average unit sales). TRx showed a y/y growth rate by 6.6% (6.3%) (4-week rolling average).

Continue reading (pdf) icon-download